Clinical Trials on Pulmonary Fibrosis in United Kingdom

Total 4922 results

Theravance Biopharma

Terminated

TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)

United Kingdom
Imperial College London

Completed

Auto-titrating Oxygen in Chronic Respiratory Failure (ASI1)

Chronic Obstructive Pulmonary Disease | Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Completed

Morphine Sulfate/Placebo for the Treatment of PulmonAry Fibrosis Cough (PAciFy Cough)

Idiopathic Pulmonary Fibrosis

United Kingdom
GlaxoSmithKline

Completed

A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom
GlaxoSmithKline

Terminated

A Validation and Dosimetry Study of GSK2634673F PET Ligand

Idiopathic Pulmonary Fibrosis

United Kingdom
Blade Therapeutics

Withdrawn

Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF

Idiopathic Pulmonary Fibrosis

United Kingdom
GlaxoSmithKline

Terminated

Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging

Idiopathic Pulmonary Fibrosis

United Kingdom
University of Nottingham
GlaxoSmithKline; McMaster University; Medical Research Council; CRAFT Consortium

Completed

Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England) (PROFILE)

Idiopathic Pulmonary Fibrosis

United Kingdom
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
GlaxoSmithKline

Completed

IPF Drug Deposition Study (TOPICAL-IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
National Institute for Health Research, United Kingdom

Completed

Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis (IPFRESP)

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
National Institute for Health Research, United Kingdom

Completed

The Predictive Ability of 4MGS in IPF (IPFMORT)

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
Kings Clinical Trials Unit

Completed

Muscle Stimulation in Advanced Idiopathic Pulmonary Fibrosis (MUST-IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom
Indalo Therapeutics, Inc.

Terminated

A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Healthy Volunteers

United Kingdom
Imperial College London
The Leeds Teaching Hospitals NHS Trust; Norfolk and Norwich University Hospitals... and other collaborators

Completed

Idiopathic Pulmonary Fibrosis Job Exposures Study (IPFJES)

Idiopathic Pulmonary Fibrosis | IPF

United Kingdom
Manchester University NHS Foundation Trust

Recruiting

Longitudinal Changes in Serum KL-6 in IPF (LOCK-IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom
University Hospitals Coventry and Warwickshire...

Unknown

Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF

Idiopathic Pulmonary Fibrosis

United Kingdom
University of East Anglia

Completed

Exhaled Breath Condensate Biomarkers and Cough in IPF

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
National Institute for Health Research, United Kingdom

Completed

Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis (IPFREL)

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Active, not recruiting

Changes in iOS in IPF

Idiopathic Pulmonary Fibrosis

United Kingdom
Norfolk and Norwich University Hospitals NHS Foundation...
Norwich Clinical Trials Unit

Recruiting

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole (TIPAL)

Idiopathic Pulmonary Fibrosis

United Kingdom
Lung Therapeutics, Inc

Completed

Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Completed

Reliability and Validity of iOS in IPF

Idiopathic Pulmonary Fibrosis

United Kingdom
Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle University

Completed

Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) (PPIPF)

Idiopathic Pulmonary Fibrosis

United Kingdom
Hull University Teaching Hospitals NHS Trust
Chiesi Farmaceutici S.p.A.

Completed

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
Actelion

Unknown

Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study (B-PHIT)

Idiopathic Pulmonary Fibrosis | Pulmonary Hypertension | Interstitial Lung Disease | Nonspecific Interstitial Pneumonia

United Kingdom
Galapagos NV

Completed

Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom, Ukraine
VA Office of Research and Development

Completed

Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis

Hypertension, Pulmonary | Fibrosis, Pulmonary | Alveolitis, Fibrosing

United States
Kingston University
University College London Hospitals; St. George's Hospital, London

Completed

Toward Self-management in ILD

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Chronic Hypersensitivity Pneumonitis | Connective Tissue Related ILD | Fibrotic Lung Disease

United Kingdom
University of East Anglia
InterMune

Unknown

Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis

Depression | Anxiety | Idiopathic Pulmonary Fibrosis | Dyspnoea

United Kingdom
Royal Brompton & Harefield NHS Foundation Trust
University of Nottingham; GlaxoSmithKline; University College, London

Completed

Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study (PROFILE)

Idiopathic Pulmonary Fibrosis | Idiopathic Non-specific Interstitial Pneumonitis

United Kingdom
University Hospital Southampton NHS Foundation...

Active, not recruiting

Structured Exercise Training Programme in Idiopathic Pulmonary Fibrosis (Rehab-IPF)

Quality of Life | Idiopathic Pulmonary Fibrosis | Breathlessness

United Kingdom
Oxford University Hospitals NHS Trust

Active, not recruiting

AI Assisted Detection of Chest X-Rays (AID-CXR)

Pneumoperitoneum | Pneumothorax | Cardiomegaly | Pleural Effusion | Atelectasis | Pulmonary Nodules, Solitary | Pneumothorax; Acute | Pleural Effusions, Chronic | Pulmonary Nodules, Multiple | Fibrosis Lung | Pulmonary Consolidation | Pulmonary Calcification

United Kingdom
Royal Victoria Infirmary
Manchester University NHS Foundation Trust

Unknown

Does CBT Improve the Perception/Impact of Cough and Breathlessness in IPF Patients

Cough | Idiopathic Pulmonary Fibrosis | Breathlessness

United Kingdom
Lung Therapeutics, Inc

Recruiting

A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients

Idiopathic Pulmonary Fibrosis

United States, United Kingdom, Germany
Boehringer Ingelheim

Completed

A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

Idiopathic Pulmonary Fibrosis

United Kingdom
Zambon SpA

Completed

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) (IFIGENIA)

Pulmonary Fibrosis

Spain, Germany, Belgium, France, Italy, Netherlands, United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Unknown

Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation

Lung Diseases | Bronchiectasis | Emphysema | Cystic Fibrosis | Alveolitis, Fibrosing

United Kingdom
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States, United Kingdom
Chiesi Farmaceutici S.p.A.

Active, not recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF

Idiopathic Pulmonary Fibrosis

North Macedonia, Ukraine, United Kingdom
Galecto Biotech AB

Completed

RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients

Idiopathic Pulmonary Fibrosis

United Kingdom
University of Oxford
Oxford University Hospitals NHS Trust

Completed

Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis

Pulmonary Fibrosis

United Kingdom
University of Dundee
British Lung Foundation; Newcastle University; University of Leicester; University... and other collaborators

Active, not recruiting

BPF Genetics of ILD Study (BPF GILD)

Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial Pneumonias | Alveolitis, Extrinsic Allergic | Lung; Disease, Interstitial, With Fibrosis | Bird Fancier's Lung

United Kingdom
Boehringer Ingelheim

Completed

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.

Idiopathic Pulmonary Fibrosis

Spain, United Kingdom, Italy, Belgium, Germany, Netherlands, Finland, Denmark
Synspira, Inc.

Terminated

A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis

Lung Diseases | Cystic Fibrosis | Pulmonary Disease | Antibiotic Resistant Infection | Respiratory Tract Disease | Cystic Fibrosis Pulmonary Exacerbation | Lung Inflammation | Burkholderia Infections | Lung Infection | Multi-antibiotic Resistance | Pulmonary Inflammation | Lung Infection Pseudomonal | Cystic Fibrosis... and other conditions

United Kingdom
Global Blood Therapeutics

Terminated

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (Zephyr)

Idiopathic Pulmonary Fibrosis | Hypoxemia

United Kingdom, United States
St George's Healthcare NHS Trust

Unknown

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

Idiopathic Pulmonary Fibrosis | Interstitial Pneumonia

United Kingdom
Novartis Pharmaceuticals

Terminated

Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Germany, Italy, Canada, Ireland, United Kingdom
Vicore Pharma AB
Orphan Reach

Completed

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Idiopathic Pulmonary Fibrosis

United Kingdom, India, Ukraine, Russian Federation
University of California, San Francisco

Completed

Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)

United States

Clinical Trials on Pulmonary Fibrosis in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations